Filing Details

Accession Number:
0001209191-18-015306
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-01 20:50:13
Reporting Period:
2018-02-28
Accepted Time:
2018-03-01 20:50:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1624298 Jossie Aspauza 800 W. Oympic Blvd.
Suite 406
Los Angeles CA 90015
Vp, Sam/Cam No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-28 2,512 $79.58 14,592 No 4 M Direct
Common Stock Disposition 2018-02-28 2,171 $92.10 12,421 No 4 D Direct
Common Stock Disposition 2018-02-28 103 $92.10 12,318 No 4 F Direct
Common Stock Acquisiton 2018-02-28 3,752 $59.98 16,070 No 4 M Direct
Common Stock Disposition 2018-02-28 2,444 $92.10 13,626 No 4 D Direct
Common Stock Disposition 2018-02-28 393 $92.10 13,233 No 4 F Direct
Common Stock Acquisiton 2018-02-28 1,048 $62.51 14,281 No 4 M Direct
Common Stock Disposition 2018-02-28 712 $92.10 13,569 No 4 D Direct
Common Stock Disposition 2018-02-28 102 $92.10 13,467 No 4 F Direct
Common Stock Acquisiton 2018-02-28 1,102 $57.19 14,569 No 4 M Direct
Common Stock Disposition 2018-02-28 685 $92.10 13,884 No 4 D Direct
Common Stock Disposition 2018-02-28 126 $92.10 13,758 No 4 F Direct
Common Stock Disposition 2018-02-28 9,995 $90.38 3,763 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 M Direct
No 4 D Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2018-02-28 2,512 $0.00 2,512 $79.58
Common Stock Stock Appreciation Rights Disposition 2018-02-28 3,752 $0.00 3,752 $59.98
Common Stock Stock Appreciation Rights Disposition 2018-02-28 1,048 $0.00 1,048 $62.51
Common Stock Stock Appreciation Rights Disposition 2018-02-28 1,102 $0.00 1,102 $57.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-06-21 2023-12-19 No 4 M Direct
0 2017-04-30 2024-04-30 No 4 M Direct
4,192 2017-05-09 2026-05-09 No 4 M Direct
4,406 2018-02-27 2027-02-27 No 4 M Direct
Footnotes
  1. The reporting person received 238 shares of common stock upon the net exercise of 2,512 stock appreciation rights ("SARs"). The reporting person forfeited 2,171 shares of common stock underlying the SARs in payment of the exercise price and 103 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
  2. The reporting person received 915 shares of common stock upon the net exercise of 3,752 SARs. The reporting person forfeited 2,444 shares of common stock underlying the SARs in payment of the exercise price and 393 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
  3. The reporting person received 234 shares of common stock upon the net exercise of 1,048 SARs. The reporting person forfeited 712 shares of common stock underlying the SARs in payment of the exercise price and 102 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
  4. The reporting person received 291 shares of common stock upon the net exercise of 1,102 SARs The reporting person forfeited 685 shares of common stock underlying the SARs in payment of the exercise price and 126 shares of common stock underlying the SARs to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 28, 2018 of $92.10.
  5. This transaction was executed in multiple trades at prices ranging from $90.11 to $90.65. The price reported reflects the weighted average sale price of $90.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. Consists of stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested May 9, 2017, and 20% will vest on May 9, 2018, and the remaining 60% will vest May 9, 2019.
  7. Consists of stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested February 27, 2018, 20% will vest February 27, 2019, and the remaining 60% will vest February 27, 2020.